175 related articles for article (PubMed ID: 18506687)
1. Blood transfusion, anesthesia, surgery and risk of non-Hodgkin lymphoma in a population-based case-control study.
Cerhan JR; Engels EA; Cozen W; Davis S; Severson RK; Morton LM; Gridley G; Hartge P; Linet M
Int J Cancer; 2008 Aug; 123(4):888-94. PubMed ID: 18506687
[TBL] [Abstract][Full Text] [Related]
2. Anthropometrics, physical activity, related medical conditions, and the risk of non-hodgkin lymphoma.
Cerhan JR; Bernstein L; Severson RK; Davis S; Colt JS; Blair A; Hartge P
Cancer Causes Control; 2005 Dec; 16(10):1203-14. PubMed ID: 16215871
[TBL] [Abstract][Full Text] [Related]
3. Non-Hodgkin lymphoma in women: reproductive factors and exogenous hormone use.
Lee JS; Bracci PM; Holly EA
Am J Epidemiol; 2008 Aug; 168(3):278-88. PubMed ID: 18550561
[TBL] [Abstract][Full Text] [Related]
4. Reproductive factors, menopausal hormone therapy, and risk of non-Hodgkin, diffuse large B-cell and follicular lymphomas: a UK case-control study.
Mildon KH; Ansell P; Roman E; Kane EV
Cancer Causes Control; 2010 Dec; 21(12):2079-83. PubMed ID: 20697798
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Evaluation of Medical Conditions Associated with Risk of Non-Hodgkin Lymphoma using Medicare Claims ("MedWAS").
Engels EA; Parsons R; Besson C; Morton LM; Enewold L; Ricker W; Yanik EL; Arem H; Austin AA; Pfeiffer RM
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1105-13. PubMed ID: 27197296
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for non-Hodgkin lymphoma subtypes defined by histology and t(14;18) in a population-based case-control study.
Chang CM; Wang SS; Dave BJ; Jain S; Vasef MA; Weisenburger DD; Cozen W; Davis S; Severson RK; Lynch CF; Rothman N; Cerhan JR; Hartge P; Morton LM
Int J Cancer; 2011 Aug; 129(4):938-47. PubMed ID: 20949561
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
Abuamsha H; Kadri AN; Hernandez AV
Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
[TBL] [Abstract][Full Text] [Related]
8. The epidemic of non-Hodgkin lymphoma in the United States: disentangling the effect of HIV, 1992-2009.
Shiels MS; Engels EA; Linet MS; Clarke CA; Li J; Hall HI; Hartge P; Morton LM
Cancer Epidemiol Biomarkers Prev; 2013 Jun; 22(6):1069-78. PubMed ID: 23595542
[TBL] [Abstract][Full Text] [Related]
9. Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998.
Eltom MA; Jemal A; Mbulaiteye SM; Devesa SS; Biggar RJ
J Natl Cancer Inst; 2002 Aug; 94(16):1204-10. PubMed ID: 12189223
[TBL] [Abstract][Full Text] [Related]
10. Family history of hematopoietic malignancy and risk of lymphoma.
Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
[TBL] [Abstract][Full Text] [Related]
11. Intake of vitamins D and A and calcium and risk of non-Hodgkin lymphoma: San Francisco Bay Area population-based case-control study.
Mikhak B; Bracci PM; Gong Z
Nutr Cancer; 2012; 64(5):674-84. PubMed ID: 22697504
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic blood transfusion as a risk factor for the subsequent development of non-Hodgkin's lymphoma.
Vamvakas EC
Transfus Med Rev; 2000 Jul; 14(3):258-68. PubMed ID: 10914420
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI-SEER multi-center case-control study.
Engels EA; Chatterjee N; Cerhan JR; Davis S; Cozen W; Severson RK; Whitby D; Colt JS; Hartge P
Int J Cancer; 2004 Aug; 111(1):76-80. PubMed ID: 15185346
[TBL] [Abstract][Full Text] [Related]
14. Occupation and Risk of Non-Hodgkin Lymphoma and Its Subtypes: A Pooled Analysis from the InterLymph Consortium.
't Mannetje A; De Roos AJ; Boffetta P; Vermeulen R; Benke G; Fritschi L; Brennan P; Foretova L; Maynadié M; Becker N; Nieters A; Staines A; Campagna M; Chiu B; Clavel J; de Sanjose S; Hartge P; Holly EA; Bracci P; Linet MS; Monnereau A; Orsi L; Purdue MP; Rothman N; Lan Q; Kane E; Costantini AS; Miligi L; Spinelli JJ; Zheng T; Cocco P; Kricker A
Environ Health Perspect; 2016 Apr; 124(4):396-405. PubMed ID: 26340796
[TBL] [Abstract][Full Text] [Related]
15. Aspirin and other nonsteroidal anti-inflammatory drugs, statins and risk of non-Hodgkin lymphoma.
Liebow M; Larson MC; Thompson CA; Nowakowski GS; Call TG; Macon WR; Kay NE; Habermann TM; Slager SL; Cerhan JR
Int J Cancer; 2021 Aug; 149(3):535-545. PubMed ID: 33644854
[TBL] [Abstract][Full Text] [Related]
16. Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends.
Howlader N; Morton LM; Feuer EJ; Besson C; Engels EA
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):174-9. PubMed ID: 26472423
[TBL] [Abstract][Full Text] [Related]
17. Trans fatty acid intake is associated with increased risk and n3 fatty acid intake with reduced risk of non-hodgkin lymphoma.
Charbonneau B; O'Connor HM; Wang AH; Liebow M; Thompson CA; Fredericksen ZS; Macon WR; Slager SL; Call TG; Habermann TM; Cerhan JR
J Nutr; 2013 May; 143(5):672-81. PubMed ID: 23486982
[TBL] [Abstract][Full Text] [Related]
18. Chronic fatigue syndrome and subsequent risk of cancer among elderly US adults.
Chang CM; Warren JL; Engels EA
Cancer; 2012 Dec; 118(23):5929-36. PubMed ID: 22648858
[TBL] [Abstract][Full Text] [Related]
19. Occupational risk factors for subgroups of non-Hodgkin's lymphoma.
Tatham L; Tolbert P; Kjeldsberg C
Epidemiology; 1997 Sep; 8(5):551-8. PubMed ID: 9270958
[TBL] [Abstract][Full Text] [Related]
20. Red blood cell membrane trans fatty acid levels and risk of non-Hodgkin lymphoma: a prospective nested case-control study.
Ardisson Korat AV; Chiu YH; Bertrand KA; Zhang S; Epstein MM; Rosner BA; Chiuve S; Campos H; Giovannucci EL; Chavarro JE; Birmann BM
Am J Clin Nutr; 2020 Dec; 112(6):1576-1583. PubMed ID: 33022699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
